Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Agnosia 2Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Kidney Neoplasms 1Ileus 1Head and Neck Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Curative Breast Cancer Surgery 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1Acute Pain 1

Interventions

Paclitaxel 328Carboplatin 323Bevacizumab 171Gemcitabine 106liposomal doxorubicin 104pembrolizumab 101Cyclophosphamide 96Topotecan 94olaparib 92Cisplatin 92niraparib 69Docetaxel 57Taxes 52Doxorubicin 51Drug Therapy 45fludarabine 40Filgrastim 39Nivolumab 37Magnetic Resonance Spectroscopy 34Surveys and Questionnaires 33Specimen Handling 33Etoposide 32Hyperthermic Intraperitoneal Chemotherapy 31Blood Specimen Collection 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Cytoreduction Surgical Procedures 25Albumin-Bound Paclitaxel 25durvalumab 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Ketorolac Tromethamine × Clear all
NCT02470299 2025-05-22

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

New Mexico Cancer Research Alliance

Phase NA Completed
21 enrolled
Gynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT01670799 2020-02-27

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

New Mexico Cancer Research Alliance

Phase EARLY_PHASE1 Completed
29 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡